New research in The FASEB Journal suggests that with magnetic guidance, specially designed nanoparticles can help deliver genes to injured arteries, using stents as the delivery platform
Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as arterial restenosis and thrombosis. In the June 2013 issue of The FASEB Journal, however, scientists report that they have discovered a new nanoparticle gene delivery method that may overcome current limitations of gene therapy vectors and prevent complications associated with the stenting procedure. Specifically, this strategy uses stents as a platform for magnetically targeted gene delivery, where genes are moved to cells at arterial injury locations without causing unwanted side effects to other organs. Additionally, magnetic nanoparticles developed and characterized in the study also protect genes and help them reach their target in active form, which also is one of the key challenges in any gene therapy.
“This study can help address a number of barriers to translation of experimental gene therapeutic approaches to clinical practice,” said Michael Chorny, Ph.D., a researcher involved in the work from the Division of Cardiology at the Abramson Pediatric Research Center at The Children’s Hospital of Philadelphia in Pennsylvania. “Bringing gene therapy closer to clinical use is a step toward developing safer and more effective ways for treating cardiovascular disease.”
To make this technique possible, Chorny and colleagues used in vitro vascular cells to demonstrate the ability to effectively deliver genes using biocompatible nanoparticles and magnetic force without causing adverse effects. Although effective gene transfer in these cells has been difficult to achieve historically, this study demonstrated that magnetically guided “gene-impregnated” nanoparticles delivered their cargo effectively, especially compared to conventional gene delivery vectors. Next, researchers explored magnetically targeted gene delivery by applying these nanoparticles to stented arteries in rats. The nanoparticle-mediated expression of stent-targeted genes was shown to be greatly enhanced in treated animals when compared to control groups treated with nanoparticles without using the magnetic conditions, or with an equivalent dose of a conventional gene delivery vector. Genes delivered using the magnetically targeted nanoparticles were also expressed at considerably higher levels in the stented arteries compared to other organs and tissues.
The Latest Bing News on:
Magnetic nanoparticles
- Magnetic Nanoparticle-based Approaches to Locally Target Therapy and Enhance Tissue Regeneration in vivoon May 3, 2024 at 5:01 pm
Alternatively, when the magnetic particle density within the scaffold is relatively high, enabling nanoparticles to experience magnetic attraction; a magnetostrictive mechanism could be employed.
- Scientists reveal nanoparticle that can treat Alzheimer’s disease in miceon May 1, 2024 at 11:45 am
Researchers say a promising new therapy targets protein clusters that likely cause neuron death and brain atrophy in Alzheimer’s disease.
- Scientists Raise Alarm Over New Invisible Indoor Air Pollutionon May 1, 2024 at 10:10 am
Engineered specks of metal in consumer cleaning products might be contributing to a new form of indoor air pollution, scientists warn. Children may be particularly at risk even after the spray has ...
- The Best MagSafe Chargers for 2024on April 30, 2024 at 5:00 pm
Here's what you need to know about Apple's magnetic charging standard, along with the best ones you can buy. I’m one of PCMag’s mobile analysts. That means I check out phones, hotspots ...
- A magnetic liquid makes for an injectable sensor in living tissueon April 30, 2024 at 5:00 pm
The researchers used their substance to make liquid bioelectronics that can be injected into the body and later retrieved. These devices seamlessly attach to biological tissue and convert ...
- Micrometeoroid Bombardment and Magnetic Fields: Decoding the Effects of Interplanetary Space on Asteroid Ryuguon April 29, 2024 at 4:55 am
Samples reveal evidence of changes experienced by the surface of asteroid Ryugu, some probably due to micrometeoroid bombardment. Analyzing samples retrieved from the asteroid Ryugu by the Japanese Sp ...
- Probing the effects of interplanetary space on asteroid Ryuguon April 29, 2024 at 2:00 am
Analyzing samples retrieved from the asteroid Ryugu by the Japanese Space Agency's Hayabusa2 spacecraft has revealed new insights into the magnetic and physical bombardment environment of ...
- Diamond dust shines bright: A safer contrast agent for MRI scanson April 27, 2024 at 1:54 am
Nanoscale diamonds unexpectedly shine brighter in MRI scans, sparking research into their potential as a novel contrast agent.
- Diamond dust shines bright in Magnetic Resonance Imagingon April 25, 2024 at 7:37 am
An unexpected discovery surprised a scientist: nanometer-sized diamond particles, which were intended for a completely different purpose, shone brightly in a magnetic resonance imaging experiment -- ...
- Antitumor Immunity by Magnetic Nanoparticle-Mediated Hyperthermiaon April 17, 2024 at 5:00 pm
20] NPrCAP-conjugated magnetic nanoparticle 10 nm Targets melanoma cells and exerts chemotherapeutic effects [21–23] Antibody-conjugated magnetic nanoparticle 20 nm Targets human breast cancer ...
The Latest Google Headlines on:
Magnetic nanoparticles
[google_news title=”” keyword=”magnetic nanoparticles” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Gene therapy
- Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progresson May 9, 2024 at 3:00 am
KateTx debuted less than a year ago with a $51 million Series A round co-led by Westlake Village BioPartners and Versant Ventures.
- Pfizer reports fatality in Phase II DMD gene therapy studyon May 7, 2024 at 11:22 pm
Pfizer has reported the death of a patient in the Phase II DAYLIGHT study of experimental gene therapy, fordadistrogene movaparvovec, to treat Duchenne muscular dystrophy (DMD). The trial is designed to assess the safety and dystrophin expression in young ...
- Michigan boy receives groundbreaking gene-editing treatment to restore visionon May 7, 2024 at 9:31 pm
An 11-year-old boy in Warren has made medical history. He is one of two children in the world to receive an experimental gene therapy procedure to restore vision.
- Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung diseaseon May 7, 2024 at 7:14 am
Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.
- CHOP gene therapy spinout raises $54M, emerges from stealth modeon May 6, 2024 at 9:59 am
A gene therapy company spun out of the Children’s Hospital of Philadelphia has emerged from stealth mode with a $54 million investment. Philadelphia-based Latus Bio last week closed the Series A financing rounding led by venture capital firms 8VC of Austin and DCVC Bio of San Francisco.
The Latest Google Headlines on:
Gene therapy
[google_news title=”” keyword=”gene therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]